Cirrhosis Diagnosis and Imaging Findings

Primary Diagnostic Significance

A nodular contour of the liver is a highly specific imaging finding that indicates cirrhosis, with the American College of Radiology guidelines identifying it as a key morphologic feature that can be assessed on ultrasound, CT, or MRI 1, 2, 3, 4, 5
The American College of Radiology recommends that a nodular liver surface be considered the most accurate imaging finding for diagnosing cirrhosis, representing the underlying pathologic process of hepatic fibrosis progressing to cirrhosis 3, 4, 5

Surface nodularity has superior sensitivity on the undersurface of the liver (86%) compared to the superior surface (53%) when evaluated by ultrasound, according to the American College of Radiology 1, 2
The positive predictive value reaches 98% when nodular surface is detected, making it one of the most reliable imaging signs of cirrhosis, as stated by the American College of Radiology 1, 2

When nodular contour is present, additional cirrhotic features that increase diagnostic confidence include atrophic right lobe with hypertrophied caudate lobe and lateral segment of left lobe, as recommended by the American College of Radiology 3, 4, 5
Other associated features include right hepatic posterior "notch", enlarged caudate-to-right lobe ratio (>0.90), expanded gallbladder fossa, narrow hepatic veins (right hepatic vein <5 mm), and enlargement of hilar periportal space (>10 mm thickness), according to the American College of Radiology guidelines 3, 4, 5

Once nodular contour confirms cirrhosis, evaluate for complications such as splenomegaly and intra-abdominal varices indicating portal hypertension, as recommended by the American Association for the Study of Liver Diseases 6, 7
Slow or reversed (hepatofugal) portal vein flow on Doppler ultrasound in advanced disease is also an important consideration, according to the American College of Radiology 4

Patients with confirmed cirrhosis require surveillance for hepatocellular carcinoma (HCC), as cirrhosis is the major risk factor for HCC development, according to the American College of Radiology 8
The presence of nodular contour mandates enrollment in HCC screening protocols regardless of etiology (hepatitis B, hepatitis C, NAFLD, or alcoholic liver disease), as recommended by the American College of Radiology 8

While nodular contour is highly specific for cirrhosis, liver biopsy may still be indicated in select cases, such as when coexisting etiologies are suspected or when treatment decisions require definitive staging, according to the American Association for the Study of Liver Diseases 6, 7, 9

These morphologic features are subjective and typically present only in later stages of fibrosis, not in early disease, as noted by the American College of Radiology 3, 4, 5
Cross-sectional imaging should confirm the abnormal contour and assess for portal hypertension features such as splenomegaly and varices, as recommended by the American Association for the Study of Liver Diseases 6, 7